Education
About Us
Working with TipRanks
Follow Us
Biophytis Sa (BPTSY)
:BPTSY
BPTSY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.23 - $18.78
Previous CloseN/A
Volume804.00
Average Volume (3M)0.00
Market Cap
$4.49M
Enterprise Value$10.24M
Total Cash (Recent Filing)€5.57M
Total Debt (Recent Filing)€8.27M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15420.51
Shares Outstanding351,174
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside557.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Biophytis News
PremiumCompany Announcements
Biophytis Completes €2.6 Million Private Placement
PremiumCompany Announcements
Biophytis Partners with AskHelpU for ALS Drug Development in China
PremiumCompany Announcements
Biophytis Advances Clinical Trials and Targets $100B Market
PremiumCompany Announcements
Biophytis Advances DMD Treatment with BIO101 Scale-Up---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTSY FAQ
What was Biophytis Sa’s price range in the past 12 months?
Biophytis Sa lowest stock price was $2.23 and its highest was $18.78 in the past 12 months.
What is Biophytis Sa’s market cap?
Biophytis Sa’s market cap is $4.49M.
When is Biophytis Sa’s upcoming earnings report date?
Biophytis Sa’s upcoming earnings report date is Nov 04, 2025 which is in 211 days.
How were Biophytis Sa’s earnings last quarter?
Currently, no data Available
Is Biophytis Sa overvalued?
According to Wall Street analysts Biophytis Sa’s price is currently Undervalued.
Does Biophytis Sa pay dividends?
Biophytis Sa does not currently pay dividends.
What is Biophytis Sa’s EPS estimate?
Biophytis Sa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biophytis Sa have?
Biophytis Sa has 351,174 shares outstanding.
What happened to Biophytis Sa’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biophytis Sa?
Currently, no hedge funds are holding shares in BPTSY
---
Company Description
Biophytis Sa
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.
---
BPTSY Stock 12 Month Forecast
Average Price Target
$15.00
▲(557.89% Upside)
Technical Analysis
Best Analysts Covering BPTSY
1 Year
Unknown AnalystH.C. Wainwright
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 2 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---